Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
TG01 + QS-21 +/- Balstilimab for Pancreatic Cancer
Recruiting1 awardPhase 2
Westwood, Kansas
This trial is testing if a new drug, TG01, and an existing drug, Balstilimab, can help pancreatic cancer patients' immune system fight cancer cells remaining after surgery. QS-21 is also used to improve the effectiveness of TG01.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.